Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134833 · ClinicalTrials.gov registry record · NA
Engaging Seronegative Youth to Optimize HIV Prevention Continuum
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 1,478
- Enrollment target
NCT03134833 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 1,478 participants.
The verdict
NCT03134833, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,478 participants
- Enrollment target
Study Summary
The focus of this study (Engaging Seronegative Youth to Optimize HIV Prevention Continuum) - will be to stop HIV-related risk acts and to encourage youth at high risk for HIV to adopt antiretroviral medications as treatment and prevention (either pre exposure prophylaxis (PrEP) or post exposure prophylaxis) among gay, bisexual and transgender and/or homeless youth with contact with the criminal justice system in the HIV epicenters of Los Angeles and New Orleans. A cohort of 1500 youth at the highest risk of seroconverting over 24 months will be identified. The goal will be to optimize the HIV Prevention Continuum over 24 months. The proposed randomized controlled trial (RCT) aims to compare youth outcomes when randomized to one of four automated and person-mediated social media delivered intervention conditions: 1) Automated Messaging and Monitoring Intervention (AMMI) only (n=900) consisting of daily motivational, instructional, and referral text-messaging (SMS), and brief, weekly SMS monitoring surveys of outcomes; 2) Peer Support through social media plus AMMI (n=200) via private online discussion boards; 3) Coaching plus AMMI (n=200) to provide service linkages, eligibility support, appointment coordination and follow-up, communication with healthcare providers, and brief motivational and strengths-based counseling for linkage and retention to prevention, mental health, and substance abuse services; and, 4) Coaching plus Peer Support and AMMI (n=200).
Interventions
- BEHAVIORAL Peer Support
- BEHAVIORAL Coaching
- BEHAVIORAL Automated Messaging & Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,478 participants |
| Start Date | 2017-05-06 |
| Est. Completion | 2022-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134833
The ClinicalTrials.gov registry entry for NCT03134833 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,478 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Peer Support is the first listed.
NCT03134833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03134833 about?
NCT03134833 is a clinical study titled "Engaging Seronegative Youth to Optimize HIV Prevention Continuum". The focus of this study (Engaging Seronegative Youth to Optimize HIV Prevention Continuum) - will be to stop HIV-related risk acts and to encourage youth at high risk for HIV to adopt antiretroviral medications as treatment and prevention (either pre exposure prophylaxis (PrEP) or post exposure prop...
What is the current status of trial NCT03134833?
This trial is currently completed. It is a NA study. The enrollment target is 1,478 participants. The study started on 2017-05-06. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT03134833?
The interventions under investigation include: Peer Support (BEHAVIORAL), Coaching (BEHAVIORAL), Automated Messaging & Monitoring (BEHAVIORAL).
Who is sponsoring clinical trial NCT03134833?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.